Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +3.94% | -20.55% | -95.43% |
Jun. 14 | CNS Pharmaceuticals, Inc. announced that it expects to receive $1.3725 million in funding | CI |
Jun. 10 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 17-08-31 |
Director of Finance/CFO | 45 | 19-11-12 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 17-11-30 |
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
John Climaco
CEO | Chief Executive Officer | 55 | 17-08-31 |
Faith Charles
CHM | Chairman | 62 | 23-01-02 |
Jeffry Keyes
BRD | Director/Board Member | 51 | 18-06-24 |
Bettina Cockroft
BRD | Director/Board Member | 57 | 23-05-07 |
Jerzy Gumulka
BRD | Director/Board Member | 74 | 17-11-07 |
Amy Mahery
BRD | Director/Board Member | 47 | Jan. 17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 237,039 | 216,763 ( 91.45 %) | 0 | 91.45 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-95.43% | 687K | |
+38.66% | 52.85B | |
+35.00% | 38.24B | |
-7.81% | 38.87B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B |
- Stock Market
- Equities
- CNSP Stock
- Company CNS Pharmaceuticals, Inc.